Tidal Investments’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDTX
RCM
HI
DGM
VC
JFG
Tidal Investments's CDTX Position: Q4 2025 in Review
Tidal Investments sold out of Cidara Therapeutics (CDTX) in Q4 2025, closing a stake of 2,649 shares — an estimated $254K sold.
Tidal Investments first reported a position in CDTX in Q3 2025 and held it in 1 quarter. The position peaked at $254K in Q3 2025. 255 funds tracked by Wall St. Rank hold CDTX as of Q4 2025.
- Tidal Investments reported no remaining Cidara Therapeutics position as of Q4 2025 after selling out during the quarter.
- Tidal Investments sold 2,649 Cidara Therapeutics shares in Q4 2025, an estimated $254K.
- Tidal Investments first reported a position in Cidara Therapeutics in Q3 2025 and held it in 1 quarter.
- Tidal Investments's Cidara Therapeutics position peaked at $254K in Q3 2025.
- 255 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q4 2025.
Based on Tidal Investments's 13F filing for Q4 2025, filed 13 Feb 2026.